Skip to main
CI

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 47%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is well-positioned for future growth with its strong partnerships with top-tier insurers like Centene and its focus on self-funding arrangements with employers. Additionally, the company's exit from the Exchange business will allow it to focus on core growth opportunities and its emphasis on high-growth areas of commercial membership with deeper integration into its subsidiary Evernorth's services will further drive growth. With strong financials, a diverse and experienced leadership team, and a commitment to sustainability, we see continued success for Cigna Group in the future.

Bears say

Cigna Group is facing execution risks in accurately managing healthcare costs, potential margin erosion in Evernorth due to transitions to a rebate-free model, and potential impacts from biosimilar adoption and client losses for Evernorth. Additionally, a rise in unemployment and economic downturn could affect its commercial membership growth. However, as a global managed care organization, Cigna is focused on improving access and affordability of healthcare, and its diverse products and services make it an attractive investment for sustainability-oriented investors. Despite potential risks, its recent multiyear deals and positive financial guidance show a strong outlook for Cigna's financial performance, making it an attractive name to own with a revised price target of $340.00 in the next 12 months.

Cigna (CI) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 47% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 17 analysts, Cigna (CI) has a Buy consensus rating as of Jul 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $345.59, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $345.59, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.